Diagnosis and Management of Gynecomastia for Urologists.

Autor: Baumgarten L; Henry Ford Health System, 2799 W. Grand Blvd, Detroit, MI, 48202, USA., Dabaja AA; Henry Ford Health System, 2799 W. Grand Blvd, Detroit, MI, 48202, USA. adabaja2@hfhs.org.
Jazyk: angličtina
Zdroj: Current urology reports [Curr Urol Rep] 2018 May 17; Vol. 19 (7), pp. 46. Date of Electronic Publication: 2018 May 17.
DOI: 10.1007/s11934-018-0796-x
Abstrakt: Purpose of Review: Our aim is to review the steps of diagnosis and management of gynecomastia with a special focus on treatment of gynecomastia associated with androgen deprivation therapy for prostate cancer.
Recent Findings: Recent studies investigating tamoxifen and radiation therapy for both therapy and prophylaxis of bicalutamide-induced gynecomastia are reviewed. Gynecomastia is a common clinical problem, affecting between one and two thirds of middle-aged men. Diagnosis is typically made by history and physical exam. Common causes include chronic medical conditions and medications; however, unexplained gynecomastia should prompt laboratory work-up, followed by appropriate imaging studies to evaluate for hormone producing cancers. For patients taking bicalutamide for treatment of prostate cancer, tamoxifen or radiation therapy for gynecomastia are excellent options.
Databáze: MEDLINE
Externí odkaz: